This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n10http://linked.opendata.cz/resource/drugbank/drug/DB04718/identifier/pdb/
n12http://linked.opendata.cz/resource/drugbank/drug/DB04718/identifier/pubchem-compound/
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n4http://linked.opendata.cz/ontology/drugbank/
n13http://linked.opendata.cz/resource/drugbank/drug/DB04718/identifier/pubchem-substance/
n5http://linked.opendata.cz/resource/drugbank/property/
n9http://linked.opendata.cz/resource/drugbank/drug/DB04718/identifier/drugbank/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04718
rdf:type
n4:Drug
n4:group
experimental
owl:sameAs
n7:DB04718 n11:DB04718
dcterms:title
(2S,3S,4R,5R,6R)-5-Amino-2-(Aminomethyl)-6-((2R,3R,4R,5S)-5-((1R,2R,3S,5R,6S)-3,5-Diamino-2-((2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yloxy)-6-hydroxycyclohexyloxy)-2-(hydroxymethyl)-4-(2-((R)-piperidin-3-ylmethylamin
adms:identifier
n9:DB04718 n10:JS5 n12:46937017 n13:46505683
n4:synonym
JS5
n4:IUPAC-Name
n5:271B4CD3-363D-11E5-9242-09173F13E4C5
n4:InChI
n5:271B4CD9-363D-11E5-9242-09173F13E4C5
n4:Molecular-Formula
n5:271B4CD8-363D-11E5-9242-09173F13E4C5
n4:Molecular-Weight
n5:271B4CD5-363D-11E5-9242-09173F13E4C5
n4:Monoisotopic-Weight
n5:271B4CD6-363D-11E5-9242-09173F13E4C5
n4:SMILES
n5:271B4CD7-363D-11E5-9242-09173F13E4C5
n4:Water-Solubility
n5:271B4CD1-363D-11E5-9242-09173F13E4C5
n4:logP
n5:271B4CCF-363D-11E5-9242-09173F13E4C5 n5:271B4CD2-363D-11E5-9242-09173F13E4C5
n4:logS
n5:271B4CD0-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Acceptor-Count
n5:271B4CDF-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Donor-Count
n5:271B4CE0-363D-11E5-9242-09173F13E4C5
n4:InChIKey
n5:271B4CDA-363D-11E5-9242-09173F13E4C5
n4:Polar-Surface-Area--PSA-
n5:271B4CDB-363D-11E5-9242-09173F13E4C5
n4:Polarizability
n5:271B4CDD-363D-11E5-9242-09173F13E4C5
n4:Refractivity
n5:271B4CDC-363D-11E5-9242-09173F13E4C5
n4:Rotatable-Bond-Count
n5:271B4CDE-363D-11E5-9242-09173F13E4C5
n4:Bioavailability
n5:271B4CE5-363D-11E5-9242-09173F13E4C5
n4:Ghose-Filter
n5:271B4CE7-363D-11E5-9242-09173F13E4C5
n4:MDDR-Like-Rule
n5:271B4CE8-363D-11E5-9242-09173F13E4C5
n4:Number-of-Rings
n5:271B4CE4-363D-11E5-9242-09173F13E4C5
n4:Physiological-Charge
n5:271B4CE3-363D-11E5-9242-09173F13E4C5
n4:Rule-of-Five
n5:271B4CE6-363D-11E5-9242-09173F13E4C5
n4:Traditional-IUPAC-Name
n5:271B4CD4-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-acidic-
n5:271B4CE1-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-basic-
n5:271B4CE2-363D-11E5-9242-09173F13E4C5